Nature Biotechnology
23, 1054 - 1058 (2005)
doi:10.1038/nbt0905-1054
Flexibility—the guiding principle for antibody manufacturingKeith L Carson
Keith L. Carson is Chairman, The Williamsburg BioProcessing Foundation, Foundation PO Box 1229, 1206 Laskin Road, Suite 201, Virginia Beach, Virginia 23451, USA. kcarson@wilbio.com
Ensuring adequate manufacturing capacity for recombinant and monoclonal antibodies is one of the greatest challenges facing the biotech industry. The following factors should be taken into account when designing product development and production strategies.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
